The $11.7-million grant was initially awarded to Clinical Data subsidiary Icoria in 2002 with the aim of creating software tools and other technologies that can better support the discovery of novel targets, drugs, and diagnostics using systems biology.
As part of the new partnership, the companies will use IO Informatics' intelligent multidimensional object, a mobile, extensible database record that transforms specific pieces or even parts of data into objects that scientists can describe, use, share, and relate to across application and database boundaries, the companies said.
The IMO will be applied to data accumulated through Clinical Data's Gene-to-Cell System approach to pharmaceutical and life science discovery, the companies said.
Further financial details were not disclosed.